Contemporary application and prospects of mesenchymal stem cell therapies in gynecology and gynecologic oncology

Serhan Can Iscan

doi:10.5281/zenodo.17282175

Authors

Serhan Can Iscan Kutahya Health Sciences University, Department of Obstetrics and Gynecology, Kutahya, Turkey https://orcid.org/0000-0002-3824-5818

DOI:

https://doi.org/10.5281/zenodo.17282175

Keywords:

Stem cells, Mesenchymal stem cell therapy, Gynecologic oncology

Abstract

Dear Editor,

Mesenchymal stem cells (MSCs) have garnered increasing interest because to their multidirectional differentiation potential, , immunomodulatory capabilities, and self-renewal capacity. Being able to comprehend the multi-omics molecular background of stem cells has the potential to offer us with important information on the treatment of diseases, including gynecological disorders, as well as the synthesis of healthy cells for use in regenerative medicine. Due to the fact that they encourage immunoregulatory, anti-inflammatory, anti-apoptotic, and anti-oxidative activities, MSCs have been proven to possess paracrine capabilities. This gives them the status of agents that are tolerant of the immune system. In addition, they possess both pain-relieving and angiogenic actions.

References

Erceg Ivkošić I, Fureš R, Ćosić V, Mikelin N, Bulić L, Dobranić D, et al. Unlocking the potential of mesenchymal stem cells in gynecology: where are we now? J Pers Med. 2023;13(8):1253.

Azizoglu SI. The pathophysiology of psychiatric disorders and the therapeutic potential of mesenchymal stem cells. Psychiatry Investig. 2025;22(9):961.

Gul MC. The pathophysiology of abdominal surgical diseases and the therapeutic potential of mesenchymal stem cells. J Clin Trials Exp Investig. 2025;4(2):59-61.

Azizoglu M, Zorba-Yildiz AP, Yilmaz H, Yurtbay G, Catli G, Yavuz G, et al. Regenerative medicine in surgery: stem cells and exosome applications. Cir Cir. 2025;93(1):86-104.

Kurniadi A, Zucha MA, Kusumanto A, Salima S, Harsono AB. Application of adult stem cells in obstetrics and gynecology: a scoping review. Eur J Obstet Gynecol Reprod Biol X. 2025;25:100367.

Gao G, Li L, Li C, Liu D, Wang Y, Li C. Mesenchymal stem cells: guardians of women's health. Regen Ther. 2024;26:1087-98.

Zhao YX, Chen SR, Su PP, Huang FH, Shi YC, Shi QY, et al. Using mesenchymal stem cells to treat female infertility: an update on female reproductive diseases. Stem Cells Int. 2019;2019:9071720.

Dai F, Liu H, He J, Wu J, Yuan C, Wang R, et al. Model construction and drug therapy of primary ovarian insufficiency by ultrasound-guided injection. Stem Cell Res Ther. 2024;15(1):49.

Un B, Cetinkaya-Un B, Akpolat M, Andic F, Yazir Y. The effects of human amnion membrane-derived mesenchymal stem cells conditioned medium on ionizing radiation-induced premature ovarian failure and endoplasmic reticulum stress-related apoptosis mechanism. Eur J Obstet Gynecol Reprod Biol. 2023;288:191-7.

Li J, Fan H, Liu W, Zhang J, Xiao Y, Peng Y, et al. Mesenchymal stem cells promote ovarian reconstruction in mice. Stem Cell Res Ther. 2024;15(1):115.

Park HS, Chugh RM, Seok J, Cetin E, Mohammed H, Siblini H, et al. Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage. Stem Cell Res Ther. 2023;14(1):165.

Nejabati HR, Nikzad S, Roshangar L. Therapeutic potential of mesenchymal stem cells in PCOS. Curr Stem Cell Res Ther. 2024;19(2):134-44.

Prayitno GD, Lestari K, Sartika CR, Djuwantono T, Widjaya A, Muharam R, et al. Potential of mesenchymal stem cells and their secretomes in decreasing inflammation markers in polycystic ovary syndrome treatment: a systematic review. Medicines (Basel). 2022;10(1):3.

de Miguel-Gómez L, López-Martínez S, Francés-Herrero E, Rodríguez-Eguren A, Pellicer A, Cervello I. Stem cells and the endometrium: from the discovery of adult stem cells to pre-clinical models. Cells. 2021;10(3):595.

Kaupinis A, Valius M, Ramašauskaitė D, Navakauskienė R. Menstrual blood-derived endometrial stem cells’ impact for the treatment perspective of female infertility. Int J Mol Sci. 2021;22(13):6774.

El Sabeh M, Afrin S, Singh B, Miyashita-Ishiwata M, Borahay MA, Segars JH, et al. Uterine stem cells and benign gynecological disorders: role in pathobiology and therapeutic implications. Stem Cell Rev Rep. 2021;17:803-20.

Lane FL, Jacobs S. Stem cells in gynecology. Am J Obstet Gynecol. 2012;207(3):149-56.

Habata S, Mamillapalli R, Ucar A, Taylor HS. Donor mesenchymal stem cells program bone marrow, altering macrophages, and suppressing endometriosis in mice. Stem Cells Int. 2023;2023:1598127.

Song Y, Liu H, Pan S, Wang X, Ma Y, Zhou J, et al. Emerging role of mesenchymal stromal cells in gynecologic cancer therapy. Stem Cell Res Ther. 2023;14:347.

Pan Y, Wang X, Li Y, Zhang J, Liu D, Chen X, et al. Human umbilical cord blood mesenchymal stem cells-derived exosomal microRNA-503-3p inhibits progression of human endometrial cancer cells through downregulating MEST. Cancer Gene Ther. 2022;29(6):1130-9.

Liu X, Zhao G, Huo X, Zhang J, Li Y, Xu B, et al. Adipose-derived stem cells facilitate ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition through activating the TGF-β pathway. Front Oncol. 2021;11:756011.

Gholizadeh-Ghaleh Aziz S, Fardyazar Z, Pashaiasl M. The human amniotic fluid mesenchymal stem cells therapy on SKOV3 ovarian cancer cell line. Mol Genet Genomic Med. 2019;7(7):e00726.